NCT02763241

Brief Summary

The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

August 9, 2018

Status Verified

August 1, 2018

Enrollment Period

2 years

First QC Date

April 29, 2016

Last Update Submit

August 7, 2018

Conditions

Keywords

rhinitis

Outcome Measures

Primary Outcomes (1)

  • Satisfaction score

    This score will be evaluated at the end of 1 month using using the satisfaction questionaire

    1 month

Secondary Outcomes (5)

  • The adherence to Cleanoze® devic

    1 month

  • The durability of the Cleanoze® device

    1 month

  • The symptoms score of the patients

    1 month

  • The Sino-Nasal Outcome Test-22 Questionnaire (SNOT-22) score

    1 month

  • Adverse events

    1 month

Study Arms (2)

Cleanoze®

EXPERIMENTAL

Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution. The patient will be instructed to use this isotonic solution for nasal irrigation daily.

Drug: Cleanoze®

Syringe irrigation

ACTIVE COMPARATOR

Nasal irrigation using sterile 0.9% NaCl 250 ml by 20 ml syringe The patient will be instructed to use this isotonic solution for nasal irrigation daily.

Drug: Saline (Syringe irrigation)

Interventions

Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.

Cleanoze®

Nasal irrigation using 250 ml normal saline pushing into the nostril by 20 ml syringe

Syringe irrigation

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Any patients with chronic rhinitis conditions regardless of any cause (e.g. allergic, irritant, infection)

You may not qualify if:

  • Acute or chronic rhinosinusitis
  • Acute nasopharyngitis (common cold)
  • Patients with a tendency to aspirate such as cerebrovascular accident, cranio-facial diseases.
  • Sinunasal, nasopharyngeal and skull base tumors
  • Age under 5 years old.
  • Cannot administer a saline irrigation under the assistant of a care giver.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otolaryngology, Khonkaen University

Muang, Khonkaen, 40002, Thailand

Location

MeSH Terms

Conditions

Rhinitis

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Patorn Piromchai, MD, MSc

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistance Professor

Study Record Dates

First Submitted

April 29, 2016

First Posted

May 5, 2016

Study Start

January 1, 2016

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

August 9, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations